<DOC>
	<DOCNO>NCT01126411</DOCNO>
	<brief_summary>The purpose study investigate , Immunoadsorption autoantibodies subsequent substitution immunoglobulin able improve haemodynamics patient pulmonary hypertension .</brief_summary>
	<brief_title>Immunoadsorption Patients With Pulmonary Hypertension</brief_title>
	<detailed_description>Increased pulmonary precapillary vascular resistance due vasoconstriction vasoproliferative process basic pathophysiological mechanism development pulmonary hypertension ( PH ) . In patient pulmonary arterial hypertension ( PH ) production endothelin-1 ( ET-1 ) increase elevate ET-1 plasma level correlate PH severity As recently show Autoantibodies Endothelin-1 Typ A Angiotensin II Typ-1 Receptor , high Incidence PH-Patients , may also play important role pathophysiology PH ( Dandel et al. ) . The concept study elimination autoantibody Immunoadsorption protein A may improve haemodynamics patient wellbeing . Immunoglobulins substitute Immunoadsorption minimize infection risk .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>pulmonary hypertension ( PH ) NYHA IIIV medical treatment PH respective current guideline 18 year old write informed consent patient pulmonary hypertension due leave ventricular dysfunction decompensated heart failure need Catecholamines active infection pregnancy malign tumor disease secondary disease life expectancy &lt; 1 year refusal patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>pulmonary hypertension</keyword>
	<keyword>autoantibody</keyword>
	<keyword>immunoadsorption</keyword>
	<keyword>immunoglobulin substitution</keyword>
	<keyword>right ventricular function</keyword>
</DOC>